Genesys International Corporation Limited (GENESYS) AI Stock Analysis

Genesys International Corporation Limited

(NSE:GENESYS)

Select Model

Rating:57Neutral

Price Target:INR 177.00▲(3.27% Upside)

Action:reiterated

Date:10/22/26

The score is supported by strong historical growth, improved profitability, and a solid equity base, but is constrained by weak cash-flow conversion and deteriorating technical momentum. The relatively high P/E and lack of dividend yield provide limited valuation support.

Positive Factors

Continued ProfitabilityThe company remained profitable in FY2026 despite weaker reported revenue and lower margins. Positive EBIT and net income provide an operating base for reinvestment, product development, and balance-sheet support, although the durability of earnings depends on restoring stronger growth and cash conversion.

Negative Factors

Severe Revenue ContractionThe extreme FY2026 revenue decline signals a substantial deterioration in business momentum and makes near-term earnings less predictable. A sustained contraction could reduce operating leverage, weaken investment capacity, and undermine the company’s ability to convert its earlier expansion into durable growth.

Genesys International Corporation Limited (GENESYS) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 11.44B
Dividend Yield: ―
Average Volume (3M): 82.97K
Price to Earnings (P/E): 23.0
Beta (1Y): 1.31
Revenue Growth: 3.73%
EPS Growth: -49.32%
Country: India
Employees: 991
Sector: General
Sector Strength: 55
Industry: Software - Application

Genesys International Corporation Limited Business Overview & Revenue Model

Company Description

Established in 1983 in Mumbai, India, Genesys International Corporation Limited operates globally, delivering a wide array of mapping, surveying, and geospatial intelligence services. The company specializes in advanced spatial data acquisition, offe...

Genesys International Corporation Limited Financial Statement Overview

Summary

Revenue growth, improved profitability, a strengthening equity base, and manageable leverage support the score. However, recent margin compression and weak, volatile cash flow materially reduce financial quality.

Income Statement

71Positive

Balance Sheet

76Positive

Cash Flow

34Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	3.38B	3.28B	3.11B	1.98B	1.81B	1.17B
Gross Profit	836.70M	862.52M	1.14B	989.36M	777.38M	358.42M
EBITDA	1.15B	1.24B	1.46B	862.12M	654.64M	-142.65M
Net Income	307.87M	325.76M	562.23M	220.73M	190.78M	134.12M
Balance Sheet
Total Assets	0	9.72B	7.78B	6.35B	5.06B	3.21B
Cash, Cash Equivalents and Short-Term Investments	1.04B	1.16B	2.24B	236.53M	1.47B	282.76M
Total Debt	0	1.73B	1.22B	595.18M	393.18M	265.00M
Total Liabilities	-7.05B	2.67B	2.21B	1.44B	981.34M	854.93M
Stockholders Equity	7.05B	7.04B	5.56B	4.89B	4.05B	2.05B
Cash Flow
Free Cash Flow	-241.39M	-44.37M	-621.29M	-645.82M	-1.33B	49.54M
Operating Cash Flow	-4.40M	102.59M	-584.49M	190.67M	-351.92M	274.78M
Investing Cash Flow	-967.08M	-1.56B	-189.33M	-796.07M	-1.88B	-200.23M
Financing Cash Flow	1.23B	1.50B	578.96M	712.43M	2.15B	119.07M

Genesys International Corporation Limited Technical Analysis

Technical Analysis SentimentNegative

Last Price171.40

Price Trends

50DMA245.92Negative

100DMA231.28Negative

200DMA211.70Negative

Market Momentum

MACD-21.98Positive

RSI23.11Positive

STOCH5.54Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:GENESYS, the sentiment is Negative. The current price of 171.40 is below the 20-day moving average (MA) of 236.75, below the 50-day MA of 245.92, and below the 200-day MA of 211.70, indicating a bearish trend. The MACD of -21.98 indicates Positive momentum. The RSI at 23.11 is Positive, neither overbought nor oversold. The STOCH value of 5.54 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:GENESYS.

Genesys International Corporation Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:GENESYS against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:INFOBEAN	85Outperform	INR 13.31B	9.09	―	0.72%	35.59%	40.03%
IN:TATAELXSI	73Outperform	INR 236.14B	35.23	―	1.98%	10.01%	-0.08%
IN:MAPMYINDIA	64Neutral	INR 43.58B	31.64	―	0.44%	1.83%	-12.91%
IN:GENESYS	57Neutral	INR 11.46B	22.97	―	―	3.73%	-49.32%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:XTGLOBAL	53Neutral	INR 3.41B	30.42	―	0.40%	33.41%	8.12%

* General Sector Average

Performance Comparison

IN:GENESYS and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:GENESYS	Genesys International Corporation Limited	171.40	-176.41	-50.72%
IN:INFOBEAN	InfoBeans Technologies Ltd.	137.29	-19.18	-12.26%
IN:MAPMYINDIA	C.E. Info Systems Ltd.	795.00	-1007.67	-55.90%
IN:TATAELXSI	Tata Elxsi Limited	3790.00	-1551.49	-29.05%
IN:XTGLOBAL	XTGlobal Infotech Ltd.	25.40	-14.09	-35.68%
IN:FRACTAL	Fractal Analytics Limited	749.45	-97.95	-11.56%

Genesys International Corporation Limited Corporate Events

Genesys International Wins ₹283 Crore Ahmedabad 3D Digital Twin Contract

Sep 24, 2026

Genesys International Corporation Limited has secured a ₹283 crore World Bank-funded contract to build a comprehensive 3D Digital Twin and Spatial Intelligence Platform for Ahmedabad, in what is described as one of India’s largest digital...

Genesys Board Clears New Auditors and Expanded ESOP Ahead of 44th AGM

Sep 2, 2026

Genesys International Corporation Limited’s board has approved the appointment of M/s. G. K. Choksi & Co. as statutory auditors for a five-year term, replacing the outgoing firm after the upcoming 44th AGM. The board also took note of the r...

Genesys International Taps Tech Mahindra Veteran Nikhil Alulkar as CEO to Drive Geospatial Expansion

Aug 17, 2026

Genesys International Corporation Limited has appointed former Tech Mahindra senior executive Nikhil Alulkar as its new chief executive officer, underscoring a strategic shift in leadership as the company enters its next phase of growth. The move is...

Genesys International publishes Q1 FY27 unaudited financial results

Aug 16, 2026

Genesys International Corporation Limited has published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026 in leading English and Marathi newspapers, in line with Indian securities disclosure regulations....

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 22, 2026

Genesys International Corporation Limited AI Stock Analysis